Bikman cites research that midface volume falls about 7% for every 10 kg lost, and says the same happens after bariatric surgery or any big weight loss.
Recap by typeshit. Post by @BenBikmanPhD on X.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
In over 61,000 matched patients, coded lymphedema hit 0.88% of GLP-1 users versus 2.58% of non-users. Authors call it hypothesis-generating, not proof.
Judge Zahid Quraishi found Novo failed to show irreparable harm, so Lilly's superiority ads stay up while the false advertising suit continues.
Loading…